Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
Date | Form | Description | Docs | XBRL | Pages |
02/26/21 | 8-K | Current report filing |
![]() ![]() |
33 | |
02/25/21 | 4 | Lederman Seth |
![]() ![]() |
1 | |
02/25/21 | 4 | Saenger Bradley |
![]() ![]() |
2 | |
02/25/21 | 4 | Morris Jessica Edgar |
![]() ![]() |
2 | |
02/25/21 | 4 | Sullivan Gregory M |
![]() ![]() |
2 | |
02/19/21 | 8-K | Current report filing |
![]() ![]() |
27 | |
02/16/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
![]() ![]() |
9 | |
02/16/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
![]() ![]() |
5 | |
02/12/21 | 5 | Saenger Bradley |
![]() ![]() |
2 | |
02/11/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
![]() ![]() |
9 |